Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Prostaglandin E2 Mediates Cough via the EP3 Receptor: Implications for Future Disease Therapy
American Journal of Respiratory and Critical Care Medicine, 09/09/09
Maher SA et al. – Identification of the receptor mediating prostaglandin E2–induced cough represents a key step in developing a drug that is anti–inflammatory and a bronchodilator but without unwanted side effects.
Related Articles
The Cough Hypersensitivity Syndrome: A Novel Paradigm for Understanding Cough
Lung, 10/15/09
Relevance Score: 91%
Cough and Sleep
Lung, 10/22/09
Relevance Score: 90%
Nitric Oxide Measurement in Chronic Cough
Lung, 10/21/09
Relevance Score: 90%
Effect of Smoking on Cough Reflex Sensitivity in Humans
Lung, 10/23/09
Relevance Score: 88%
Postnasal drip and chronic cough: An open interventional study
Respiratory Medicine, 10/13/09
Relevance Score: 88%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells
British Journal of Cancer, 12/18/09
Increase in Passive Stiffness at Reduced Airway Smooth Muscle Length: Potential Impact on Airway Responsiveness
Lung Cellular and Molecular Physiology, 12/18/09
Modulation of epithelial sodium channel activity by lipopolysaccharide in alveolar type II cells: Involvement of purinergic signaling
Lung Cellular and Molecular Physiology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


